|
gptkbp:instanceOf
|
gptkb:medical_emergency
gptkb:disease
|
|
gptkbp:affects
|
gptkb:skin
mucous membranes
|
|
gptkbp:age
|
all ages
|
|
gptkbp:alsoKnownAs
|
gptkb:SJS
|
|
gptkbp:cause
|
gptkb:unknown
gptkb:adverse_drug_reaction
infection
|
|
gptkbp:complication
|
gptkb:pneumonia
blindness
sepsis
organ failure
permanent skin damage
|
|
gptkbp:diagnosedBy
|
clinical evaluation
skin biopsy
|
|
gptkbp:field
|
immunology
internal medicine
dermatology
|
|
gptkbp:firstDescribed
|
1922
|
|
gptkbp:frequency
|
rare
|
|
gptkbp:ICD-10_code
|
L51.1
|
|
gptkbp:mortalityRate
|
5-10%
|
|
gptkbp:namedAfter
|
gptkb:Albert_Mason_Stevens
gptkb:Frank_Chambliss_Johnson
|
|
gptkbp:notableDrugCauses
|
gptkb:NSAIDs
antibiotics
allopurinol
anticonvulsants
|
|
gptkbp:relatedTo
|
gptkb:toxic_epidermal_necrolysis
|
|
gptkbp:riskFactor
|
immunosuppression
HIV infection
certain genetic factors
|
|
gptkbp:symptom
|
fever
fatigue
sore throat
blisters
painful red or purplish rash
skin peeling
|
|
gptkbp:treatment
|
supportive care
pain management
wound care
hospitalization
antibiotics (if infection present)
discontinuation of causative agent
fluid replacement
|
|
gptkbp:bfsParent
|
gptkb:Manute_Bol
|
|
gptkbp:bfsLayer
|
5
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Stevens–Johnson syndrome
|